Intravenous Infusions (XGHA:IIL) Non Operating Income: GHS Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:IIL Intravenous Infusions Ltd XGHA:IIL
3 GF Score
Price GHS0.46
View Full Analysis

What is Intravenous Infusions Non Operating Income?

Intravenous Infusions XGHA:IIL +6.98% 3 Non Operating Income is GHS Mil as of . 20. GuruFocus rates XGHA:IIL with a GF Score™ of 3/100.

Non Operating Income is income or expense that comes from miscellaneous sources. Intravenous Infusions's Non Operating Income for the six months ended in . 20 was GHS0.00 Mil.

Intravenous Infusions Non Operating Income Related Terms

Intravenous Infusions Non Operating Income Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Non Operating Income Chart

Intravenous Infusions Annual Data
Trend
Non Operating Income

Intravenous Infusions Semi-Annual Data
Non Operating Income
XGHA:IIL
3GF Score
Intravenous Infusions Ltd XGHA:IIL
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intravenous Infusions Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of GHS Mil mean?
Intravenous Infusions (XGHA:IIL) has a Non Operating Income of GHS Mil as of . 20. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Non Operating Income too high?
Intravenous Infusions' current Non Operating Income is GHS Mil. Overall, Intravenous Infusions has a GF Score™ of 3/100, reflecting its overall financial health beyond just this single metric.
How does Intravenous Infusions' Non Operating Income compare to PTLF and PCYN?
Intravenous Infusions' Non Operating Income of GHS Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Non Operating Income is GHS Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Non Operating Income of GHS Mil. The current Non Operating Income is GHS Mil. Intravenous Infusions' overall GF Score™ is 3/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Non Operating Income is GHS Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.
3GF Score

Get the complete analysis for XGHA:IIL

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.46
Price